December 8, 2014 4:05 pm

Boston Business Journal: Merck to Purchase Cubist Pharmaceuticals for $8.4B

Merck will buy Cubist Pharmaceuticals for $8.4 billion, illustrating a new emphasis on combating so-called “superbugs” that have drawn dire warnings from global health organizations.

US & World Videos

0:20

Trash room fire sparks at Boston apartment building
0:25

Electrical failure causes outages, smoking manhole covers in Everett
2:23

Search for suspect after sexual assault reported in Cambridge
4:09

Budgets, staffing, and social media can all impact violence in schools, administrators say
2:35

Sumner Tunnel closed for weekend
Exit mobile version